TLI
Total Lymphoid Irradiation (TLI) is a form of radiation therapy used primarily for patients undergoing organ transplantation or those with certain autoimmune diseases. TLI involves the administration of low-dose radiation to the lymphoid tissues in the body, which includes the lymph nodes, spleen, and thymus. The goal of TLI is to suppress the immune system in a controlled manner to prevent organ rejection in transplant patients or to reduce the severity of autoimmune responses.
Overview[edit | edit source]
Total Lymphoid Irradiation works by targeting the lymphoid tissues, which are critical components of the immune system. These tissues contain lymphocytes, a type of white blood cell that plays a significant role in immune responses. By irradiating these areas, TLI aims to reduce the number and activity of lymphocytes, thereby decreasing the immune system's ability to attack transplanted organs or, in the case of autoimmune diseases, the body's own tissues.
Indications[edit | edit source]
TLI is primarily indicated for patients who are undergoing organ transplantation, such as kidney, heart, or lung transplants. It is also used in the treatment of certain autoimmune diseases, including but not limited to, Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Multiple Sclerosis.
Procedure[edit | edit source]
The TLI procedure involves the patient receiving radiation therapy over several sessions. The total dose and number of sessions can vary depending on the patient's condition and the specific goals of treatment. The radiation is carefully targeted to minimize exposure to non-lymphoid tissues and reduce potential side effects.
Benefits and Risks[edit | edit source]
The primary benefit of TLI is its potential to increase the success rate of organ transplants by reducing the risk of rejection. In patients with autoimmune diseases, TLI can decrease disease activity and improve symptoms. However, like all treatments, TLI carries risks. These can include acute side effects such as nausea, fatigue, and an increased risk of infections due to the suppression of the immune system. Long-term risks may include an increased risk of developing secondary cancers.
Conclusion[edit | edit source]
Total Lymphoid Irradiation is a specialized form of radiation therapy that plays a crucial role in the management of organ transplant patients and certain autoimmune diseases. While it offers significant benefits, the risks associated with immune suppression and radiation exposure must be carefully weighed against these benefits. As with any medical treatment, the decision to proceed with TLI should be made on an individual basis, considering the specific circumstances and health status of the patient.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD